The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study

The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study

IntroductionPatients with inflammatory bowel disease (IBD) have a high risk of developing extra-intestinal manifestations (EIMs). We aimed to assess the cumulative incidence and clinical course of EIMs in patients treated with Vedolizumab (VDZ) and non-gut selective biologic drugs.Materials and meth...

Full description

Bibliographic Details
Main Authors: Francesca Ferretti, Maria Camilla Monico, Rosanna Cannatelli, Stefania Carmagnola, Marco Vincenzo Lenti, Antonio Di Sabatino, Francesco Conforti, Luca Pastorelli, Flavio Caprioli, Cristina Bezzio, Simone Saibeni, Stefano Mazza, Maurizio Vecchi, Giovanni Maconi, Sandro Ardizzone
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
inflammatory bowel disease
extra-intestinal manifestations (EIMs)
biologic therapy
Vedolizumab
TNF inhibitors
Ustekinumab
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.933357/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.933357/full

Similar Items